Abstract
For three decades 6-mercaptopurine (6MP), an analog of hypoxan-thine, has been used in the treatment of acute lymphoblastic leukemia (ALL). Only in recent years sensitive and specific methods for the determination of 6MP and closely related drugs like 6-thioguanine (6TG) and azathioprine (AZA) have become available. The study of the pharmacokinetics of these drugs is possible now in animals and man, employing dose levels which are common in clinical practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
De Abreu RA, Van Baal JM, Schouten TJ, Schretlen EDAM, De Bruyn CHMM. High-performance liquid chromatographic determination of plasma 6-mercaptopurine in clinically relevant concentrations. J Chromatogr 1982;227:526–533.
Tidd DM, Kim SC, Horakova K, Moriwaki A, Paterson ARP. A delayed cytotoxic reaction for 6-mercaptopurine. Cancer Res 1972;32:317–322
Tidd DM, Paterson ARP. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 1974;34:738–746.
Tidd DM, Paterson ARP. Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 1974;34:733–737.
Nelson JA, Carpenter JW, Rose LM, Adamson DJ. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine. Cancer Res 1975;35:2872–2878.
Wotring LL, Roti JL. Thioguanine-induced S and G2 blocks and their significance to the mechanism of cytotoxicity. Cancer Res 1980;40:1458–1462.
Elion GB. Biochemistry and pharmacology of purine analogues. Fed Proc 1967;26:898–904.
Lee SH, Sartorelli AC. The effects of inhibitors of DNA biosynthesis on the cytotoxicity of 6-thioguanine. Cancer Biochem Biophys 1981;5:189–194.
Brox LW, Birkett L, Belch A. Clinical pharmacology of oral thioguanine in acute myelogenous leukemia. Cancer Chemother Pharmacol 1981;6:35–38.
Goldie JH, Coldman AJ, Gudauskas GA. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 1982; 66:439–449.
Green DM, Freeman AL, Sather HN et al. Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia. Lancet 1980;i: 1398–1402.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schouten, T.J. et al. (1984). 6-Mercaptopurine: Pharmacokinetics in Animals and Preliminary Results in Children. In: De Bruyn, C.H.M.M., Simmonds, H.A., Müller, M.M. (eds) Purine Metabolism in Man-IV. Advances in Experimental Medicine and Biology, vol 165. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0390-0_69
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0390-0_69
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0392-4
Online ISBN: 978-1-4757-0390-0
eBook Packages: Springer Book Archive